1. Home
  2. AL vs CRSP Comparison

AL vs CRSP Comparison

Compare AL & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AL
  • CRSP
  • Stock Information
  • Founded
  • AL 2010
  • CRSP 2013
  • Country
  • AL United States
  • CRSP Switzerland
  • Employees
  • AL N/A
  • CRSP N/A
  • Industry
  • AL Diversified Commercial Services
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AL Consumer Discretionary
  • CRSP Health Care
  • Exchange
  • AL Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • AL 4.7B
  • CRSP 4.9B
  • IPO Year
  • AL 2011
  • CRSP 2016
  • Fundamental
  • Price
  • AL $59.98
  • CRSP $51.83
  • Analyst Decision
  • AL Buy
  • CRSP Buy
  • Analyst Count
  • AL 5
  • CRSP 16
  • Target Price
  • AL $61.40
  • CRSP $72.27
  • AVG Volume (30 Days)
  • AL 758.8K
  • CRSP 2.5M
  • Earning Date
  • AL 08-04-2025
  • CRSP 08-04-2025
  • Dividend Yield
  • AL 1.47%
  • CRSP N/A
  • EPS Growth
  • AL 76.97
  • CRSP N/A
  • EPS
  • AL 8.24
  • CRSP N/A
  • Revenue
  • AL $2,873,037,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • AL $12.27
  • CRSP $11.17
  • Revenue Next Year
  • AL $6.29
  • CRSP $296.09
  • P/E Ratio
  • AL $7.28
  • CRSP N/A
  • Revenue Growth
  • AL 6.15
  • CRSP N/A
  • 52 Week Low
  • AL $38.25
  • CRSP $30.04
  • 52 Week High
  • AL $61.10
  • CRSP $71.13
  • Technical
  • Relative Strength Index (RSI)
  • AL 67.69
  • CRSP 40.26
  • Support Level
  • AL $57.01
  • CRSP $51.80
  • Resistance Level
  • AL $60.84
  • CRSP $55.30
  • Average True Range (ATR)
  • AL 1.09
  • CRSP 2.23
  • MACD
  • AL 0.38
  • CRSP -0.58
  • Stochastic Oscillator
  • AL 94.03
  • CRSP 4.66

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: